Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IV Kytril for prevention of postoperative nausea and vomiting after pediatric tonsil surgery
2016-003260-39Phase 4
- Sponsor
- Roche
- Start
- Aug 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of granisetron in postoperative nausea and vomiting (PONV) (2 arms), sponsored by Roche. Primary endpoint: Percentage of participants with total control of postoperative nausea and vomiting over the 2 hours following extubation.
02
Drugs
granisetron
03
Conditions
postoperative nausea and vomiting (PONV)
Beyond the preview
Go deeper on 2016-003260-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-003260-39.